Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task

Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task

Interleukin 10 (IL-10) belongs to IL-10 family cytokines that are critical for maintaining the integrity of epithelial tissues, protecting pathogenic infection, and preventing excessive immune responses to damage self. Temporal IL-10 signaling blockade enhances vaccine-induced tumor regression by CD...

Full description

Bibliographic Details
Main Authors: Guoying Ni, Lu Zhang, Xiaodan Yang, Hejie Li, Bowei Ma, Shelley Walton, Xiaolian Wu, Jianwei Yuan, Tianfang Wang, Xiaosong Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2020-10-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
interleukin 10
pd-1
cancer immunotherapy
Online Access:http://dx.doi.org/10.1080/21645515.2020.1717185

Internet

http://dx.doi.org/10.1080/21645515.2020.1717185

Similar Items